Company: ISRG
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001035267-25-000192
Chunk: 119

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 2
Chunk 119
---
 to approximately $1.44 million for the three months ended June 30, 2024. The higher second quarter 2025 ASP was largely driven by favorable product mix, including from da Vinci 5 system placements, partially offset by more trade-ins. ASP fluctuates from period to period based on geographic and product mix, product pricing, systems placed involving trade-ins, and changes in foreign exchange rates.

During the second quarter of 2025, 54 Ion systems were placed compared to 74 systems during the second quarter of 2024. By geography, 47 systems were placed in the U.S., three in Europe, two in Asia, and two in other markets during second quarter of 2025, compared to 72 systems placed in the U.S. and two in Europe during the second quarter of 2024. In the U.S., where we estimate that penetration of lung biopsy is approaching the halfway point, our customers’ focus has begun to shift from increasing capacity to increasing utilization of their existing systems. As of June 30, 2025, we had an Ion system installed base of approximately 905 systems, compared to an installed base of approximately 678 systems as of June 30, 2024.

The following table summarizes our Ion system placements and systems installed at customers under leasing arrangements:

Three Months Ended June 30,20252024Ion System Placements under Leasing ArrangementsFixed-payment operating lease arrangements13 16 Usage-based operating lease arrangements21 24 Total Ion system placements under operating lease arrangements34 40 % of Total Ion system placements63%54%Sales-type lease arrangements2 — Total Ion system placements under leasing arrangements36 40 Ion System Installed Base under Operating Leasing ArrangementsFixed-payment operating lease arrangements127 116 Usage-based operating lease arrangements231 159 Total Ion system installed base under operating leasing arrangements358 275 

Six Months Ended June 30, 2025

Product revenue increased by 20% to $3.94 billion for the six months ended June 30, 2025, compared to $3.27 billion for the six months ended June 30, 2024.

Instruments and accessories revenue increased by 18% to $2.84 billion for the six months ended June 30, 2025, compared to $2.40 billion for the six months ended June 30, 2024. The increase in instruments and accessories revenue was primarily driven by approximately 17% higher da